Cerebrospinal fluid in COVID-19: a systematic review of the literature

A Lewis, J Frontera, DG Placantonakis, J Lighter… - Journal of the …, 2021 - Elsevier
Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

[HTML][HTML] Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis

RT Pinzon, VO Wijaya, A Al Jody, PN Nunsio… - Journal of infection and …, 2022 - Elsevier
Background Several studies have reported prolonged symptoms especially neurological
symptoms following acute infection in patients with COVID-19, known as long COVID-19 …

Encephalitis in patients with COVID-19: a systematic evidence-based analysis

MA Islam, C Cavestro, SS Alam, S Kundu, MA Kamal… - Cells, 2022 - mdpi.com
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) predominantly
infects the respiratory system, several investigations have shown the involvement of the …

Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies

R Zamani, R Pouremamali, N Rezaei - Reviews in the Neurosciences, 2022 - degruyter.com
Growing evidence demonstrates the association of encephalitis, meningoencephalitis or
encephalomyelitis, with SARS-CoV-2 infection. This study aims to determine the profile and …

Cerebrospinal Fluid Analysis Post–COVID‐19 Is Not Suggestive of Persistent Central Nervous System Infection

F Schweitzer, Y Goereci, C Franke, S Silling… - Annals of …, 2022 - Wiley Online Library
This study was undertaken to assess whether SARS‐CoV‐2 causes a persistent central
nervous system infection. SARS‐CoV‐2–specific antibody index and SARS‐CoV‐2 RNA …

Neurological manifestations of COVID-19: a systematic review and detailed comprehension

ZH Ousseiran, Y Fares… - International Journal of …, 2023 - Taylor & Francis
The current pandemic caused by severe acute respiratory syndrome corona virus 2 (SARS-
CoV-2) is accompanied with a rapid increase of reports and papers detailing its neurological …

Use of antioxidants for the neuro-therapeutic management of COVID-19

N Cardenas-Rodriguez, C Bandala, A Vanoye-Carlo… - Antioxidants, 2021 - mdpi.com
Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of …

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on …

NN Kleineberg, S Knauss, E Guelke… - European journal of …, 2021 - Wiley Online Library
Background and purpose During acute coronavirus disease 2019 (COVID‐19) infection,
neurological signs, symptoms and complications occur. We aimed to assess their clinical …

Clinical implications of COVID-19 presence in CSF: systematic review of case reports

I Elmakaty, K Ferih, O Karen, A Ouda, A Elsabagh… - Cells, 2022 - mdpi.com
This systematic review focused on severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) patients that had detected SARS-CoV-2 virus in cerebrospinal fluid (CSF). A …

Clinical symptoms, diagnosis, treatment, and outcome of COVID‐19‐associated encephalitis: A systematic review of case reports and case series

M Koupaei, N Shadab Mehr… - Journal of clinical …, 2022 - Wiley Online Library
Introduction Since COVID‐19 outbreak, various studies mentioned the occurrence of
neurological disorders. Of these, encephalitis is known as a critical neurological …